Showing results (661-670 of 8,523) with videos related to
Sort By:
Pageof 853
Alimentary Pharmacology & Therapeutics|December 7, 2017
Regional gastrointestinal contractility parameters using the wireless motility capsule: inter-observer reproducibility and influence of age, gender and study countryA D Farmer, A-M L Wegeberg, B Brock, et al.Alimentary Pharmacology & Therapeutics|December 2, 2017
Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in EgyptH Omar, W El Akel, T Elbaz, et al.Alimentary Pharmacology & Therapeutics|December 12, 2017
The long-term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infectionJ Jalanka, A Hillamaa, R Satokari, et al.Alimentary Pharmacology & Therapeutics|December 6, 2017
Systematic review: human gut dysbiosis induced by non-antibiotic prescription medicationsQ Le Bastard, G A Al-Ghalith, M Grégoire, et al.Alimentary Pharmacology & Therapeutics|February 2, 2019
Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkersAmmar Hassanzadeh Keshteli, Karen L Madsen, Rupasri Mandal, et al.Alimentary Pharmacology & Therapeutics|February 5, 2019
The evolution and impact of sarcopenia pre- and post-liver transplantationRahima A Bhanji, Naoki Takahashi, Michael R Moynagh, et al.Alimentary Pharmacology & Therapeutics|February 5, 2019
Review article: shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome - translating knowledge from systems biology to the bedsideSilvia Sookoian, Carlos J PirolaAlimentary Pharmacology & Therapeutics|January 22, 2019
Randomised clinical trial: pregabalin vs placebo for irritable bowel syndromeYuri A Saito, Ann E Almazar, Katherine E Tilkes, et al.Alimentary Pharmacology & Therapeutics|December 27, 2019
Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitisJacob E Ollech, Sujaata Dwadasi, Victoria Rai, et al.Alimentary Pharmacology & Therapeutics|March 13, 2018
Platelet-leucocyte aggregation is augmented in cirrhosis and further increased by platelet transfusionS Støy, V C Patel, J P Sturgeon, et al.Pageof 853